-
Mashup Score: 2
All investigated ablative methods continue to represent effective treatment choices in renal cell carcinoma, and these findings support multi-disciplinary discussions of these treatment methods, along with surgery and surveillance, to individualise treatment decisions in these patients. Future research should aim to conduct randomised controlled trials across larger patient populations to further elucidate the long-term oncological and survival outcomes associated with these treatments.
Source: www.thelancet.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 26Atlanta's Top Doctors 2024 - 7 month(s) ago
Every summer we present a roster of the best metro Atlanta doctors, as chosen by their peers. It seems to grow every year, and this year is no different. Here are 1,200+ of the areaās most trusted physicians.
Source: www.atlantamagazine.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6Good News About Brain Cancer - 7 month(s) ago
Immunotherapy is making tumors melt away.
Source: nymag.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Good News About Brain Cancer - 7 month(s) ago
Immunotherapy is making tumors melt away.
Source: nymag.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1
Mudit Chowdhary on prostate cancer for National Menās Health Month / cancer, family history, Mudit Chowdhary, National Menās Health Month, Northside Hospital,
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8Simultaneous focal boost with stereotactic radiotherapy for localised intermediate to high-risk prostate cancer: Primary outcomes of the SPARC phase II trial - 10 month(s) ago
: Dose escalated radiotherapy is associated with better biochemical control at the expense of toxicity. Stereotactic body radiotherapy (SBRT) with dose escalation to the dominant intraprostatic lesion (DIL) provides a logical approach to improve outcomes in high-risk disease whilst limiting toxicity. This study evaluated the toxicity and quality of life (QOL) with CyberKnife-based SBRT and simultaneous integrated boost in localised prostate cancer.
Source: www.redjournal.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 35UGA to launch new School of Medicine - AU/UGA Medical Partnership - 12 month(s) ago
With its vote on Feb. 13, the University System of Georgia Board of Regents authorized the University of Georgia to establish a new independent School of Medicine in Athens. The initiation of a school of medicine at Georgiaās flagship university comes at a time when the state faces a significant shortage of medical professionals. In [ā¦]
Source: medicalpartnership.usg.eduCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 13
While surgery to remove rectal cancer can be necessary and lifesaving, it can sometimes come with significant drawbacks, like loss of bowel control. According to a study led by Wilmot Cancer Institute …
Source: medicalxpress.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 16The rise of negative portrayals of radiation oncology: A textual analysis of media news - 1 year(s) ago
There has been growing concern about the media’s negative portrayal of radiation oncology in recent years. Our study shows changes in media sentiment ā¦
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 99Help me support LUNGevity Foundation! - 1 year(s) ago
I’m raising funds to support LUNGevity Foundationās amazing work for people affected by lung cancer. Will you help me reach my fundraising goal?
Source: fundraise.lungevity.orgCategories: General Medicine News, Hem/OncsTweet
RT @_ShankarSiva: š¢šØ Hot off the press @TheLancetOncol for #kidneycancer! https://t.co/v4fXO17tLp. SABR vs thermal ablation; - Despite ā«ageā¦